Seventure leads Series A round for Eligo Bioscience
MIT spin-off Eligo Bioscience has raised 2 million euros in Series A funding. Seventure led the round. Based in Paris, Eligo is an antibiotics maker.
9 July 2015•3 mins read
MIT spin-off Eligo Bioscience has raised 2 million euros in Series A funding. Seventure led the round. Based in Paris, Eligo is an antibiotics maker.
